Encapsulation state of messenger RNA inside lipid nanoparticles

Abstract

Understanding the structure of messenger RNA (mRNA) lipid nanoparticles, and specifically the microenvironment of the mRNA molecules within these entities, is fundamental to advancing their biomedical potential. Here, we show that a permeating cationic dye, thionine, can serve as a cryogenic electron microscopy contrasting agent by binding selectively to encapsulated mRNA without disturbing lipid nanoparticle morphology. Cryo-electron microscopy images identify the mRNA location, revealing that mRNA may exist within solvent-filled cavities or may be substantially lipid associated.

References 26

1. 1.

   Kowalski P.S., Rudra A., Anderson D.G. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol. Ther. 2019;27:710-728.

   Not in our library10.1016/j.ymthe.2019.02.012

2. 2.

   Karikó K. In vitro-transcribed mRNA therapeutics: out of the shadows and into the spotlight. Mol. Ther. 2019;27:691-692.

   Not in our library10.1016/j.ymthe.2019.03.009

3. 3.

   Sahin U., Karikó K., Türeci Ö. mRNA-based therapeutics--developing a new class of drugs. Nat. Rev. Drug Discov. 2014;13:759-780.

   Not in our library10.1038/nrd4278

4. 4.

   Jackson L.A., Anderson E.J., Beigel J.H., mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2 - preliminary report. N. Engl. J. Med. 2020;383:1920-1931.

   Not in our library10.1056/nejmoa2022483

5. 5.

   Guan S., Rosenecker J. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Ther. 2017;24:133-143.

   Not in our library10.1038/gt.2017.5

6. 6.

   Reichmuth A.M., Oberli M.A., Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther. Deliv. 2016;7:319-334.

   Not in our library10.4155/tde-2016-0006

7. 7.

   Semple S.C., Akinc A., Hope M.J. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 2010;28:172-176.

   Not in our library10.1038/nbt.1602

8. 8.

   Whitehead K.A., Dorkin J.R., Anderson D.G. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 2014;5:4277.

   Not in our library10.1038/ncomms5277

9. 9.

   Miao L., Li L., Anderson D.G. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 2019;37:1174-1185.

   Not in our library10.1038/s41587-019-0247-3

10. 10.

    Gindy M.E., DiFelice K., Boardman D. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery. Langmuir. 2014;30:4613-4622.

    Not in our library10.1021/la500630h

11. 11.

    Leung A.K., Tam Y.Y., Cullis P.R. Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems. J. Phys. Chem. B. 2015;119:8698-8706.

    Not in our library10.1021/acs.jpcb.5b02891

12. 12.

    Yanez Arteta M., Kjellman T., Lindfors L. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc. Natl. Acad. Sci. USA. 2018;115:E3351-E3360.

    Not in our library10.1073/pnas.1720542115

13. 13.

    Viger-Gravel J., Schantz A., Emsley L. Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy. J. Phys. Chem. B. 2018;122:2073-2081.

    Not in our library10.1021/acs.jpcb.7b10795

14. 14.

    Oberli M.A., Reichmuth A.M., Blankschtein D. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett. 2017;17:1326-1335.

    Not in our library10.1021/acs.nanolett.6b03329

15. 15.

    Eygeris Y., Patel S., Sahay G. Deconvoluting lipid nanoparticle structure for messenger RNA delivery. Nano Lett. 2020;20:4543-4549.

    Not in our library10.1021/acs.nanolett.0c01386

16. 16.

    Kulkarni J.A., Witzigmann D., Cullis P.R. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale. 2019;11:9023-9031.

    Not in our library10.1039/c9nr02004g

17. 17.

    Kulkarni J.A., Darjuan M.M., Cullis P.R. On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA. ACS Nano. 2018;12:4787-4795.

    Not in our library10.1021/acsnano.8b01516

18. 18.

    Patel S., Ryals R.C., Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J. Control. Release. 2019;303:91-100.

    Not in our library10.1016/j.jconrel.2019.04.015

19. 19.

    Richner J.M., Himansu S., Diamond M.S. Modified mRNA vaccines protect against Zika virus infection. Cell. 2017;168:1114-1125.e10.

    Not in our library10.1016/j.cell.2017.02.017

20. 20.

    Rozmanov D., Baoukina S., Tieleman D.P. Density based visualization for molecular simulation. Faraday Discuss. 2014;169:225-243.

    Not in our library10.1039/c3fd00124e

21. 21.

    Scarff C.A., Fuller M.J.G., Iadanza M.G. Variations on negative stain electron microscopy methods: tools for tackling challenging systems. J. Vis. Exp. 2018;132:57199.

    Not in our library10.3791/57199

22. 22.

    Paul P., Kumar G.S. Toxic interaction of thionine to deoxyribonucleic acids: elucidation of the sequence specificity of binding with polynucleotides. J. Hazard. Mater. 2010;184:620-626.

    Not in our library10.1016/j.jhazmat.2010.08.081

23. 23.

    Khan A.Y., Suresh Kumar G. Spectroscopic studies on the binding interaction of phenothiazinium dyes, azure A and azure B to double stranded RNA polynucleotides. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2016;152:417-425.

    Not in our library10.1016/j.saa.2015.07.091

24. 24.

    Antony T., Atreyi M., Rao M.V.R. Interaction of methylene blue with transfer RNA--a spectroscopic study. Chem. Biol. Interact. 1995;97:199-214.

    Not in our library10.1016/0009-2797(95)03616-t

25. 25.

    Gopal A., Zhou Z.H., Gelbart W.M. Visualizing large RNA molecules in solution. RNA. 2012;18:284-299.

    Not in our library10.1261/rna.027557.111

26. 26.
    Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers · 2017

    No notice

Cited by papers we hold 3

• Payload distribution and capacity of mRNA lipid nanoparticles · 2022
  No notice
• mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability · 2021
  No notice
• Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.